Fig. 1
The process of cross-sectional analysis and prospective follow-up of AF patients in this study. AF: Atrial fibrillation, OAC: Oral anticoagulant, NOAC: Non-vitamin K antagonist oral anticoagulant
Fig. 1 | BMC Cardiovascular Disorders